| Literature DB >> 32190220 |
Mohammad Sofiabadi1, Fatemeh Samiee-Rad2.
Abstract
AIM: This study examined the healing potential of royal jelly on the acetic acid induced wounds healing in male rat's gastric mucosa.Entities:
Keywords: Gastric ulcer; Rat; Royal jelly
Year: 2020 PMID: 32190220 PMCID: PMC7069531
Source DB: PubMed Journal: Gastroenterol Hepatol Bed Bench ISSN: 2008-2258
Effects of royal jelly and omepersole on gastric histopathologic and histomorphometric of acetic ulcerated rats (Mean±SD)
| Histopathological analysis | Control (n=6) | Omeprazole (n=6) | Jel50 (n=6) | Jel200 (n=6) |
|---|---|---|---|---|
| Day 4 | ||||
| PMNs | 78±9.72 | 67.5±3.22 | 61.5±1.32 | 47.75±1.02 b |
| Fibroblast | 20.75±2.13 | 23.75±1.98 | 25±1.22 | 29.25±1.49 a |
| Vascular no. | 9.75±1.49 | 12.75±1.18 | 12.75±0.96 | 18±0.82 b |
| Epithelization | 0.00 | 0.00 | 0.00 | 1 |
| Day 7 | ||||
| PMNs | 43.25±2.65 | 34.75±1.88 | 32.75±2.28 | 20.5±1.65 b c |
| Fibroblast | 29.00±3.02 | 41.25±2.89 | 37.75±1.95 | 52.25±1.43b |
| Vascular no. | 16.5±1.70 | 26±1.52a | 25.5±2.08a | 26.25±.91b |
| Epithelization | 1 | 1 | 1 | 2 |
| Day 10 | ||||
| PMNs | 24.75±2.05 | 18.5±1.93a | 12.5±1.44a | 8.75±3.02 b |
| Fibroblast | 31.25±1.68 | 44.25±2.39 | 44.5±2.29a | 53.75±4.87b |
| Vascular no. | 22.75±1.75 | 33. 25±2.32a | 33.75±2.73a | 36.75±3.02a |
| Epithelization | 2 | 3 | 3 | 3 |
| Day 15 | ||||
| PMNs | 7.60±0.8 | 4.5±0.9 b | 3.75±0.8 | 4.25±0. 9 a |
| Fibroblast | 37.75±4.16 | 49.25±1.88 | 46.5±3.15 | 48.75±1.75 |
| Vascular no. | 14.75±1.75 | 21.25±3.22 | 22.75±1.67 | 28.00±1.29a |
| Epithelization | 3 | 4 | 4 | 4 |
a Significantly different from the control group (p<0.05).
b Significantly different from the control group (p<0.01).
C Significantly different from the omeprazole group (p<0.05).
Omeprazole (20 mg/kg); RJ, Royal Jelly (50, 200 mg/kg); Depth of ulcer: Micrometer
Effects of royal jelly and omepersole on the gastric ulcer healing of acetic ulcerated rats (Mean±SD)
| Ulcer healing | Control | Omeprazole | Jel50 | Jel200 |
|---|---|---|---|---|
| Day 4 | ||||
| Depth of ulcer (µm) | 812.5±23.93 | 712.5±23.56a | 700±20.41a | 625±14.43b |
| Day 7 | ||||
| Depth of ulcer | 587.5±23.43 | 412.5±31.45a | 425±20.41a | 405±14.43b |
| Day 10 | ||||
| Depth of ulcer | 425±14.43 | 325±14.62a | 317.5±11.93 | 240±13.54b |
| Day 15 | ||||
| Depth of ulcer | 150±12.43 | 63.75±13.67b | 64.5±12.81b | 37.5±9.68b |
a Significantly different from the control group (p<0.05).
b Significantly different from the control group (p<0.01).
Omeprazole (20 mg/kg); RJ, Royal Jelly (50, 200 mg/kg); Depth of ulcer: Micrometer
Figure 1Histopathologic findings of rat’s gastric ulcer healing in different groups. (a) Normal stomach mucosa of control non -ulcerated rats (x 400). (b) Deep sited gastric ulcer in the 4th-day of control's rats (x100). (c) Gastric mucosa in RJ 200 treated rats showed the loss of superficial epithelium and sloughed glandular epithelial cells (x40). (d) Stomach mucosa in Omeprazole treated group showed mucosal necrosis(x400). (e,f,g,h) Ulcer in the 7th-day gastric ulcer healing in control, omeprazole, RJ50, and RJ200 groups rats, respectively(x400). (i) Granulation tissue organization, fibroblastic proliferation, and collagen deposition in the 10th-day gastric ulcer healing in RJ200 group rats (x400)